- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03276247
Iron Status in Women of Reproductive Age Reproductive Age
September 7, 2017 updated by: Victor Gordeuk
Ethnic and Genetic Factors of Iron Status in Women of Reproductive Age
Analyzed iron status, HFE mutations and ethnicity for women in five primary care centers in the United States and Canada using de-identified data from the HEIRS study.
Study Overview
Detailed Description
HEIRS included a cross-sectional screening study of 101,168 patients, 25 years of age or older, in the primary care setting.
Participants were recruited from four centers in the U.S .and
one in Canada from February 2001 to February 2003.
We will evaluate results for women aged 25-44 years of age who are self-reported as Asian, Black, Hispanic or White.
The lower detection limit for the serum ferritin (SF) assay in the HEIRS study was 15 μg/L and therefore the definition of iron deficiency will be SF concentration ≤ 15 μg/L.
Elevated SF concentrations, possibly indicative of elevated iron stores, will be classified by two definitions: 1) SF concentration > 300 μg/L and 2) SF >200 μg/L in combination with TSAT >45%.
Proportions will be compared by Pearson's chi-square.
Logistic regression models will be used to identify independent associations with measures of iron deficiency and elevated iron stores.
Study Type
Observational
Enrollment (Actual)
22042
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- University of Illinois at Chicago
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 44 years (Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Primary care women included in the HEIRS study.
Description
Inclusion Criteria:
- primary care women included in the HEIRS study with in the age range of this study
- Self designation as Asian American, African American, Hispanic American or White.
Exclusion Criteria:
- Age >44 years
- Self-described ethnicity other in than inclusion criterion 2.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Asian American non-pregnant
Women 25 to 44 years of age recruited in a primary care setting and self reported as Asian American and non-pregnant/non-breastfeeding.
|
observation
|
African American non-pregnant
Women 25 to 44 years of age recruited in a primary care setting and self reported as African American and non-pregnant/non-breastfeeding.
|
observation
|
Hispanic American non-pregnant
Women 25 to 44 years of age recruited in a primary care setting and self reported as Hispanic American and non-pregnant/non-breastfeeding.
|
observation
|
White non-pregnant
Women 25 to 44 years of age recruited in a primary care setting and self reported as white and non-pregnant/non-breastfeeding.
|
observation
|
Asian American pregnant
Women 25 to 44 years of age recruited in a primary care setting and self reported as Asian American and pregnant or breastfeeding.
|
observation
|
African American pregnant
Women 25 to 44 years of age recruited in a primary care setting and self reported as African American and pregnant or breastfeeding.
|
observation
|
Hispanic American pregnant
Women 25 to 44 years of age recruited in a primary care setting and self reported as Hispanic American and pregnant or breastfeeding.
|
observation
|
White pregnant
Women 25 to 44 years of age recruited in a primary care setting and self reported as White and pregnant or breastfeeding.
|
observation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Elevated serum ferritin
Time Frame: One measurement was made at the time of recruitment and this is the measurement that will be analyzed.
|
Serum ferritin >300 ug/L
|
One measurement was made at the time of recruitment and this is the measurement that will be analyzed.
|
Elevated serum ferritin and transferrin saturation
Time Frame: One measurement was made at the time of recruitment and this is the measurement that will be analyzed.
|
Serum ferritin >200 ug/L and transferrin saturation >45%
|
One measurement was made at the time of recruitment and this is the measurement that will be analyzed.
|
Iron deficiency
Time Frame: One measurement was made at the time of recruitment and this is the measurement that will be analyzed.
|
Serum ferritin <15ug/L
|
One measurement was made at the time of recruitment and this is the measurement that will be analyzed.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Victor R Gordeuk, MD, University of Illinois at Chicago
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Actual)
August 1, 2017
Study Completion (Actual)
August 1, 2017
Study Registration Dates
First Submitted
September 1, 2017
First Submitted That Met QC Criteria
September 7, 2017
First Posted (Actual)
September 8, 2017
Study Record Updates
Last Update Posted (Actual)
September 8, 2017
Last Update Submitted That Met QC Criteria
September 7, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HEIRS-womenrepage
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron Metabolism Disorders
-
Donat R. SpahnUniversity of ZurichCompletedIron-deficiency | Anemia | HypophosphatemiaSwitzerland
-
University of ZurichActive, not recruiting
-
Novartis PharmaceuticalsCompletedTransfusional Iron OverloadItaly
-
ApoPharmaCompletedTransfusional Iron OverloadEgypt, Cyprus, Oman, Saudi Arabia, Turkey
-
HaEmek Medical Center, IsraelUnknown
-
Rennes University HospitalMinistry of Health, FranceCompleted
-
RDC Clinical Pty LtdNot yet recruiting
-
Universiti Putra MalaysiaActive, not recruiting
-
Swiss Federal Institute of TechnologyJomo Kenyatta University of Agriculture and TechnologyCompletedIron-deficiency | Iron Absorption | Ferritin Threshold | Stable Iron IsotopesKenya
-
Novartis PharmaceuticalsCompletedChronic Iron OverloadGermany
Clinical Trials on observation
-
University of MichiganKuwait Foundation for the Advancement of SciencesCompletedGingival RecessionUnited States
-
Centre Hospitalier Régional d'OrléansCompleted
-
Istanbul University - Cerrahpasa (IUC)CompletedBrachial Plexus Palsy | Obstetric; InjuryTurkey
-
Abant Izzet Baysal UniversityRecruitingMultiple SclerosisTurkey
-
Universidad Autonoma de MadridCompleted
-
Universidad Autonoma de MadridUnknown
-
University of BergenEuropean Society of Intensive Care MedicineCompletedCritical Illness | Old Age; Debility | SurvivalNorway
-
Istanbul Medeniyet UniversityIstinye University; Ufuk UniversityRecruiting
-
IRCCS San Camillo, Venezia, ItalyUniversità Politecnica delle Marche; University of GenovaUnknown
-
Dokuz Eylul UniversityIzmir Katip Celebi UniversityCompleted